期刊文献+

前列腺癌根治术后病理分期、Gleason评分与术前血清PSA的相关性分析 被引量:10

Correlation of serum PSA with Gleason score and pathological stage after radical prostatectomy in patients with prostate cancer
下载PDF
导出
摘要 目的探讨前列腺癌患者根治术后病理分期、Gleason评分与术前血清PSA的相关性。方法收集香港中文大学附属威尔斯亲王医院泌尿外科2008年1月至2010年9月采用4-臂daVinci S-HD机器人外科手术系统施行前列腺根治性切除术的100例前列腺癌患者的临床资料数据,采用Spearman等级相关分析探讨根治术后病理分期、Gleason评分与术前血清PSA的相关性。结果患者PSA值与Gleason评分呈正相关(r=0.382,P<0.01),PSA值越高,Gleason评分值越高。PSA值与病理分期无明确的相关性(r=-0.073,P>0.05)。结论前列腺癌患者术前血清PSA与根治术后Gleason评分有关,与病理分期无明确的相关性。 Objective To investigate the correlation of serum prostate specific antigen (PSA) with Gleason score and pathological stage after radical prostatectomy in patients with prostate cancer. Methods A survey has been performed on 100 inpatients with prostate cancer who underwent robot-assisted laparoscopic radical prostatectomy (rLRP) using the da Vinci robotic surgical system from Jan 2008 to Sep 2010 in the surgery department, urology division of the Prince of Wales Hospital at The Chinese University of Hong Kong. Spearman rank correlation was applied to evaluate the correlation of serum total PSA with Gleason score and path- ological stage after radical prostatectomy. Results Serum total PSA was significantly positively correlated with Gleason score ( r = 0.382, P 〈 0. 01 ), but not significantly correlated with pathological stage ( r = - 0. 073, P 〉 0.05). Conclusion Serum total PSA is correlated with Gleason score but not correlated with pathological stage after radical prostatectomy in patients with prostate cancer.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第1期78-80,共3页 Journal of Third Military Medical University
关键词 前列腺癌 前列腺特异性抗原 GLEASON评分 病理分期 prostatic cancer prostate specific antigen Gleason score pathological stage
  • 相关文献

参考文献14

  • 1Pinsky PF,Andriole G,Crawford E D,et al.Prostate-specific antigenvelocity and prostate cancer gleason grade and stage[J].Cancer,2007,109(8):1689-1695.
  • 2Guimaraes M S,Quintal M M,Meirelles L R,et al.Gleason score aspredictor of clinicopathologic findings and biochemical(PSA)progres-sion following radical prostatectomy[J].Int Braz J Urol,2008,34(1):23-29.
  • 3Blute M L,Bergstralh E J,Iocca A,et al.Use of Gleason score,pros-tate specific antigen,seminal vesicle and margin status to predict bio-chemical failure after radical prostatectomy[J].J Urol,2001,165(1):119-125.
  • 4Greene F L,Page D L,Fleming I D,et al.AJCC Cancer StagingHandbook[M].6th ed.New York:Springer,2002:15-17.
  • 5Gleason D F,Mellinger G T.Prediction of prognosis for prostatic ade-nocarcinoma by combined histological grading and clinical staging[J].J Urol,1974,111(1):58-64.
  • 6胡望平,冯福英,叶桂云,肖少林,章宏斌,王海林,郑苗.血清c-PSA及C/T在提高前列腺癌诊断特异性中的探讨[J].第三军医大学学报,2007,29(18):1815-1817. 被引量:7
  • 7Rusu D,Rusu V,Stefanescu C,et al.A comparaison between the total PSA,the Gleason score and the bone scintiscan results for different agegroups[J].Rev Med Chir Soc Med Nat Iasi,2010,114(2):476-483.
  • 8Humphrey P A.Gleason grading and prognostic factors in carcinoma ofthe prostate[J].Mod Pathol,2004,17(3):292-306.
  • 9Ramos J,Uchio E,Aslan M,et al.Changes in Gleason scores forprostate cancer:what should we expect from a measurement?[J].JInvestig Med,2010,58(4):625-628.
  • 10Nayyar R,Singh P,Gupta N P,et al.Upgrading of Gleason score onradical prostatectomy specimen compared to the pre-operative needlecore biopsy:an Indian experience[J].Indian J Urol,2010,26(1):56-59.

二级参考文献31

  • 1Han M,Gann PH,Catalona WJ.Prostate-specific antigen and screening for prostate cancer.Med Clin North Am 2004;88(2):245-265
  • 2Lieberman R.Evidence-based medical perspectives:the evolving role of PSA for early detection,monitoring of treatment response,and as a surrogate end point of efficacy for interventiOns in men with different clinical risk states for the prevention and progression of prostate cancer.Am J Ther 2004;11(6):501-506
  • 3Punglia RS,D'Amico AV,Catalona WJ,et al.Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.N Engl J Med 2003;349(4):335-342
  • 4Morgan TO,Jacobsen SJ,McCarthy WF,et al.Age-specific reference ranges for prostate-specific antigen in black men.N Engl J Med 1996;335(5):304-310
  • 5Morgan TO,McLeod DG,Leifer ES,et al.Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen.Urology 1996;48(6A Suppl):76-80
  • 6Gann PH,Ma J,Catalona WJ,et al.Strategies combining total and percent free prostate specific antigen for detecting prostate cancer:a prospective evaluation.J Urol 2002;167(6):2427-2434
  • 7Denmeade SR,Isaacs JT.The role of prostate-specific antigen in the clinical evaluation of prostatic disease.BJU Int 2004;93(Suppl 1):10-15
  • 8Okihara K,Cheli CD,Partin AW,et al.Comparative analysis of complexed prostate specific antigen,free prostate specific antigen and their ratio in detecting prostate cancer.J Urol 2002;167(5):2017-2023
  • 9Zhu H,Roehl KA,Antenor JA,et al.Clinical value of longitudinal free-to-total prostate specific antigen ratio slope to diagnosis of prostate cancer.J Urol 2004;171(2Pt 1):661-663
  • 10Martinez M,Espana F,Royo M,et al.The proportion of prostate-specific antigen(PSA)complexed to alpha (1)-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 microg/L.Clin Chem 2002;48(8):1251-1256

共引文献13

同被引文献77

  • 1陈兴发,贺大林.前列腺穿刺活检诊断前列腺癌的历史与现状[J].泌尿外科杂志(电子版),2009,1(2):1-4. 被引量:1
  • 2曹希亮,高江平,韩刚,唐杰,洪宝发.以前列腺特异抗原水平分组筛查与前列腺穿刺阳性率的关系[J].中华外科杂志,2006,44(6):372-375. 被引量:21
  • 3温希平,赵慧丽.前列腺特异性抗原及相关指标检测在前列腺癌筛查中的作用[J].中国现代医生,2007,45(09Z):35-36. 被引量:4
  • 4Ophir J, Cespedes I, Ponnekanti H, et al. Elastogra phy: a quantitative method for imaging the elasticity of biologicaltissues[Jj. UhrasonImaging, 1991, 13:111 -134.
  • 5Kamoi K, Okihara K, Ochiai A, et al. The utility oftransrectal real-time elastography in the diagnosis of prostate cancer[J]. Ultrasound Med Biol, 2008, 34: 1025-1032.
  • 6杜广,袁维祥,李东,等.前列腺增生和前列腺癌患者血、尿中PSA糖链结构的改变及意义[J].中围男科学杂志,2008,22(6):33-35.
  • 7Luciani L G, De Giorgi G, Valotto C, et al. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/ml and abnormal digital rectal examination findings[J]. U- rology, 2006, 67: 555-558.
  • 8Aigner F, Pallwein L, Junker D, et al. Value of real- time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ ml or greater and 4.00 ng/ml or less[J]. J Urol, 2010, 184: 913-917.
  • 9Ophir J, Alam S K, Garra B, et al. Elastography: ul- trasonic estimation and imaging of the elastic properties of tissues[J]. Proc Inst Mech Eng H, 1999, 213(3): 203-233.
  • 10Cochlin D L, Ganatra R H, Griffiths D F. Elastogra- phy in the detection of prostatic cancer[J]. Clin Radi ol, 2002, 57: 1014-1020.

引证文献10

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部